Dr Reddys (Germany) Market Value
| RDDA Stock | EUR 13.50 0.10 0.75% |
| Symbol | RDDA |
Dr Reddys 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dr Reddys' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dr Reddys.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Dr Reddys on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Dr Reddys Laboratories or generate 0.0% return on investment in Dr Reddys over 30 days. Dr Reddys is related to or competes with Superior Plus, NMI Holdings, SIVERS SEMICONDUCTORS, Talanx AG, 2G ENERGY, NorAm Drilling, and Identiv. Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide More
Dr Reddys Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dr Reddys' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dr Reddys Laboratories upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 6.92 | |||
| Value At Risk | (2.76) | |||
| Potential Upside | 2.74 |
Dr Reddys Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Reddys' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dr Reddys' standard deviation. In reality, there are many statistical measures that can use Dr Reddys historical prices to predict the future Dr Reddys' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | 0.4588 |
Dr Reddys Laboratories Backtested Returns
Dr Reddys Laboratories retains Efficiency (Sharpe Ratio) of -0.0817, which denotes the company had a -0.0817% return per unit of price deviation over the last 3 months. Dr Reddys exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dr Reddys' Information Ratio of (0.15), standard deviation of 1.53, and Market Risk Adjusted Performance of 0.4688 to check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of -0.26, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Dr Reddys are expected to decrease at a much lower rate. During the bear market, Dr Reddys is likely to outperform the market. At this point, Dr Reddys Laboratories has a negative expected return of -0.12%. Please make sure to confirm Dr Reddys' coefficient of variation, variance, and the relationship between the mean deviation and standard deviation , to decide if Dr Reddys Laboratories performance from the past will be repeated in the future.
Auto-correlation | 0.22 |
Weak predictability
Dr Reddys Laboratories has weak predictability. Overlapping area represents the amount of predictability between Dr Reddys time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dr Reddys Laboratories price movement. The serial correlation of 0.22 indicates that over 22.0% of current Dr Reddys price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | -0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Dr Reddys Laboratories lagged returns against current returns
Autocorrelation, which is Dr Reddys stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dr Reddys' stock expected returns. We can calculate the autocorrelation of Dr Reddys returns to help us make a trade decision. For example, suppose you find that Dr Reddys has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dr Reddys regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dr Reddys stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dr Reddys stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dr Reddys stock over time.
Current vs Lagged Prices |
| Timeline |
Dr Reddys Lagged Returns
When evaluating Dr Reddys' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dr Reddys stock have on its future price. Dr Reddys autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dr Reddys autocorrelation shows the relationship between Dr Reddys stock current value and its past values and can show if there is a momentum factor associated with investing in Dr Reddys Laboratories.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in RDDA Stock
When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:Check out Dr Reddys Correlation, Dr Reddys Volatility and Dr Reddys Alpha and Beta module to complement your research on Dr Reddys. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Dr Reddys technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.